Slideshow Image 1
Shire - Human Genetic Therapies



Your doctor can determine if VPRIV is right for you. VPRIV is a hydrolytic lysosomal glucocerebroside-specific enzyme indicated for long-term enzyme replacement therapy (ERT) for pediatric and adult patients with type 1 Gaucher disease.

Find out more information about starting treatment with VPRIV.

For more information about Gaucher disease, including other types of the condition, go to